Product Information
ZARXIO 300 MCG/0.5 ML SYRINGE is a brand biologic product labeled by Sandoz Inc., priced at $532.7178 per ML under NDC 61314031801. Its NADAC has been published 123 times since Apr 17, 2024.
Strength
300 ug/.5mL
Manufacturer
Sandoz Inc.NDC
61314031801
Classification
Brand Biologic
Dosage Form
INJECTION, SOLUTION
Route
INTRAVENOUS; SUBCUTANEOUS
Effective Date
8/19/2026
Active Ingredients
FILGRASTIMApproval Type
Biologic (BLA)
FDA Application
BLA125553On Market Since
3/6/2015
Pharmacological Classes
Price Statistics
The NADAC for ZARXIO 300 MCG/0.5 ML SYRINGE has been published 123 times since Apr 17, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $532.7178 per ML |
|---|---|
| All-time high | $534.3527 (Sep 10, 2025) |
| All-time low | $526.4500 (Aug 21, 2024) |
| 52-week high | $534.3527 |
| 52-week low | $532.7178 |
| Median price | $532.7178 |
| Average price | $531.2392 |
| Largest weekly change | +0.6% (May 21, 2025) |
| Weeks tracked | 123 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ZARXIO 300 MCG/0.5 ML SYRINGE?
The current National Average Drug Acquisition Cost (NADAC) for ZARXIO 300 MCG/0.5 ML SYRINGE, manufactured by Sandoz Inc., is $532.7178 per ML (NDC 61314031801), effective Aug 19, 2026.
How has the price of ZARXIO 300 MCG/0.5 ML SYRINGE changed over time?
Over the history we have for it, the NADAC for ZARXIO 300 MCG/0.5 ML SYRINGE has held within roughly two percent of its current level. It has been tracked across 123 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for ZARXIO 300 MCG/0.5 ML SYRINGE?
Since Apr 17, 2024, the NADAC for ZARXIO 300 MCG/0.5 ML SYRINGE has ranged from a low of $526.4500 (Aug 21, 2024) to a high of $534.3527 (Sep 10, 2025), with a median of $532.7178 per ML.
Are there cheaper alternatives to ZARXIO 300 MCG/0.5 ML SYRINGE?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ZARXIO 300 MCG/0.5 ML SYRINGE, is $529.7696 per ML — about 1% below ZARXIO 300 MCG/0.5 ML SYRINGE.
Who manufactures ZARXIO 300 MCG/0.5 ML SYRINGE?
ZARXIO 300 MCG/0.5 ML SYRINGE (NDC 61314031801) is labeled by Sandoz Inc., and CMS classifies it as a brand biologic product.